Apogee Therapeutics (APGE) Interest & Investment Income (2023 - 2026)
Apogee Therapeutics (APGE) reported Interest & Investment Income of $8.7 million for Q1 2026, up 11.48% year-over-year from $7.8 million in Q1 2025, and little changed on a QoQ basis from $8.7 million in Q4 2025.
Apogee Therapeutics (APGE) has 4 years of Interest & Investment Income data on file, last reported at $8.7 million in Q1 2026.
- Quarterly Interest & Investment Income rose 11.48% year-over-year to $8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.9 million (down 15.25% YoY) and the FY2025 annual result came in at $30.0 million, down 13.56% from the prior year.
- Interest & Investment Income steadied at $8.7 million in Q1 2026 per APGE's latest filing, from $8.7 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $10.3 million in Q2 2024 and bottomed at $133000.0 in Q1 2023.
- The 4-year median for Interest & Investment Income is $7.5 million (2025), against an average of $6.9 million.
- The widest annual swing landed in 2024, when Interest & Investment Income soared 4476.69%; it then slumped 34.65% in 2025.
- Tracing APGE's Interest & Investment Income over 4 years: stood at $5.4 million in 2023, then soared by 60.17% to $8.7 million in 2024, then gained by 0.58% to $8.7 million in 2025, then advanced by 0.1% to $8.7 million in 2026.
- Per Business Quant, the three latest APGE Interest & Investment Income figures stand at $8.7 million (Q1 2026), $8.7 million (Q4 2025), and $6.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Apogee Therapeutics | 5.53 Bn | 4.47 Bn | - | 8.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.74 Mn |
| Dec 31, 2025 | 8.73 Mn |
| Sep 30, 2025 | 6.32 Mn |
| Jun 30, 2025 | 7.14 Mn |
| Mar 31, 2025 | 7.84 Mn |
| Dec 31, 2024 | 8.68 Mn |
| Sep 30, 2024 | 9.67 Mn |
| Jun 30, 2024 | 10.31 Mn |
| Mar 31, 2024 | 6.09 Mn |
| Dec 31, 2023 | 5.42 Mn |
| Sep 30, 2023 | 3.47 Mn |
| Mar 31, 2023 | 133,000.00 |